Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung
- PMID: 2435259
Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung
Abstract
Immunohistologic markers have been of considerable value in differentiating malignant mesothelioma from adenocarcinoma. Recently, staining for milk-fat globule (MFG) protein has been suggested as a useful diagnostic test for this separation, but subsequent reports have been conflicting, with some authors finding clearcut differences, while others showed similar marking of both tumor types. To examine this technique further, we studied lung carcinomas and mesotheliomas with commercially available anti-MFG, and compared these results with those obtained with anticarcinoembryonic antigen (CEA), a commonly used immunomarker of carcinoma. We found that carcinomas showed strong cytoplasmic staining for MFG and CEA; however, a greater percentage of carcinomas were more strongly positive for CEA than for MFG. Mesotheliomas did not, for the most part, stain strongly with either antibody. In addition, carcinomas from different hospitals stained differently for MFG, but not for CEA. We conclude that although strong cytoplasmic staining for MFG is a reasonably reliable indicator of carcinoma, CEA staining provides a better separation and is considerably easier to interpret in lung cancer specimens.
Similar articles
-
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.Am J Pathol. 1986 May;123(2):212-9. Am J Pathol. 1986. PMID: 2422942 Free PMC article.
-
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.Am J Surg Pathol. 1989 Apr;13(4):276-91. Am J Surg Pathol. 1989. PMID: 2648877
-
Evaluation of membranous staining of mesothelioma.Cell Vis. 1998 Jan-Feb;5(1):24-7. Cell Vis. 1998. PMID: 9660721
-
Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small-cell lung carcinoma with only two stains in most cases.Histopathology. 2023 Feb;82(3):385-392. doi: 10.1111/his.14783. Epub 2022 Sep 5. Histopathology. 2023. PMID: 36008876 Review.
-
Immunophenotyping of malignant mesothelioma.Am J Surg Pathol. 1997 Dec;21(12):1395-8. doi: 10.1097/00000478-199712000-00001. Am J Surg Pathol. 1997. PMID: 9414182 Review. No abstract available.
Cited by
-
Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours.Virchows Arch A Pathol Anat Histopathol. 1989;415(6):509-21. doi: 10.1007/BF00718644. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2508309
-
Peritoneal mesothelioma.Postgrad Med J. 1990 Oct;66(780):866-8. doi: 10.1136/pgmj.66.780.866. Postgrad Med J. 1990. PMID: 2099435 Free PMC article.
-
Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases.J Cancer Res Clin Oncol. 1994;120(6):331-47. doi: 10.1007/BF01247458. J Cancer Res Clin Oncol. 1994. PMID: 8138558 Free PMC article.
-
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.Am J Pathol. 1992 Oct;141(4):827-33. Am J Pathol. 1992. PMID: 1357974 Free PMC article.
-
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.Am J Pathol. 1990 Feb;136(2):421-8. Am J Pathol. 1990. PMID: 2305835 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical